Table of DCVMN companies involved in COVID-19 vaccine development (2/2)

Stanford University

DCVMN, or the Developing Countries Vaccine Manufacturers Network, is a cohort of 41 multinational vaccine manufacturers in Africa, the Middle East, Latin America, and Asia involved in vaccine development from the research to supply stages. The manufacturers work to benefit both local communities as well as international consumers, and they have contributed to the efforts against coronavirus. 13 of the DCVMN organizations have an understanding of international regulations for supply, as well as vaccines with WHO-prequalified vaccine status. 

DCVMN Involvement

Pagliusi, S., Jarrett, S., Hayman, B., Kreysa, U., Prasad, S. D., Reers, M., Hong Thai, P., Wu, K., Zhang, Y. T., Baek, Y. O., Kumar, A., Evtushenko, A., Jadhav, S., Meng, W., Dat, D. T., Huang, W., & Desai, S. (2020). Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply. Vaccine, 38(34), 5418–5423. https://doi.org/10.1016/j.vaccine.2020.06.022

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287474/

Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply


Compilation of 2019 data, online research about COVID-19 vaccine activity by DCVMN organizations, and supply capacity surveys were used to analyze the potential of DCVMN member organizations in the following areas:
- Research, Development, and Technology
- Scaling
- Fill-finish and distribution
- Supply of other vaccines

Learn Before

Related

Learn After